scholarly journals Retrograde Endoscopic Sclerotherapy for Management of Internal Haemorrhoids

2020 ◽  
Vol 7 (51) ◽  
pp. 3122-3125
Author(s):  
Sanjay Gupta ◽  
Bindu Aggarwal
Keyword(s):  
Clinical Practice ◽  
Prospective Study ◽  
Injection Sclerotherapy ◽  
Endoscopic Sclerotherapy ◽  
Limited Data ◽  
Endoscopic Injection Sclerotherapy ◽  
Endoscopic Injection ◽  
Common Cause ◽  
A Prospective Study

BACKGROUND Haemorrhoids are one of the most common anorectal conditions encountered in clinical practice and are recognised as a common cause of rectal bleeding, perianal itching and anal discomfort. Therapeutic treatment of haemorrhoids needs to be tailored according to grades and complication of haemorrhoids, patient preference and expertise of procedure. Very limited data is available regarding effectiveness of retrograde endoscopic injection sclerotherapy for the management of bleeding haemorrhoids. We wanted to study the effectiveness of retrograde endoscopic sclerotherapy (REST) for the management of various grades of bleeding internal haemorrhoids. METHODS A prospective study, included 87 patients with Gr. I, II and Gr. III symptomatic bleeding internal haemorrhoids. They were subjected to retrograde endoscopic sclerotherapy using Inj. Polidocanol to study its effectiveness in controlling bleeding. Effectiveness of the procedure was defined by stoppage of bleeding at 3 months follow up. RESULTS Bleeding stopped in 95.3 % cases after retrograde endoscopic sclerotherapy at 3 months follow up. No significant complications were observed with the procedure during the study period. CONCLUSIONS Retrograde endoscopic sclerotherapy is a safe, well tolerated and effective modality for the management of bleeding internal haemorrhoids. KEYWORDS Haemorrhoids, Retrograde Endoscopic Sclerotherapy

Endoscopic injection sclerotherapy for 1,000 patients with esophageal varices: A nine-year prospective study

Hepatology ◽  
1992 ◽  
Vol 15 (1) ◽  
pp. 69-75 ◽  
Author(s):  
Makoto Hashizume ◽  
Seigo Kitano ◽  
Nobuhiro Koyanagi ◽  
Kazuo Tanoue ◽  
Masayuki Ohta ◽  
...  
Keyword(s):  
Prospective Study ◽  
Esophageal Varices ◽  
Injection Sclerotherapy ◽  
Endoscopic Injection Sclerotherapy ◽  
Endoscopic Injection

Development of the Cruveilhier-Baumgarten Syndrome after Endoscopic Obliteration of Oesophageal Varices

1989 ◽  
Vol 30 (4) ◽  
pp. 401-402 ◽  
Author(s):  
J. B. Dilawari ◽  
Y. K. Chawla ◽  
U. Kaur
Keyword(s):  
Liver Cirrhosis ◽  
Injection Sclerotherapy ◽  
Oesophageal Varices ◽  
Endoscopic Injection Sclerotherapy ◽  
Endoscopic Injection

A patient with post-necrotic liver cirrhosis, presenting with recurrent haematemesis and melena due to oesophageal varices, received repeated endoscopic injection sclerotherapy. The Cruveilhier-Baumgarten syndrome developed 11 months after variceal obliteration. Neither rebleeding nor recurrence of varices was observed during a follow up period of 12 months after obliteration of varices.

Prognosis following endoscopic injection sclerotherapy for esophageal varices in adults: 20-year follow-up study

2008 ◽  
Vol 43 (10) ◽  
pp. 1269-1274 ◽  
Author(s):  
Mika Yuki ◽  
Hideaki Kazumori ◽  
Shyun Yamamoto ◽  
Toshihiro Shizuku ◽  
Yoshikazu Kinoshita
Keyword(s):  
Esophageal Varices ◽  
Injection Sclerotherapy ◽  
Endoscopic Injection Sclerotherapy ◽  
Endoscopic Injection ◽  
Follow Up Study

A transparent cap assisted endoscopic injection sclerotherapy for the treatment of patients with esophageal varices

2020 ◽  
Author(s):  
Jing Wang ◽  
Xiaohua Zhang ◽  
Shulei Zhao
Keyword(s):  
Esophageal Varices ◽  
Injection Sclerotherapy ◽  
Endoscopic Injection Sclerotherapy ◽  
Endoscopic Injection ◽  
Esophageal Variceal ◽  
Esophageal Variceal Bleeding ◽  
Transparent Cap ◽  
The Mean ◽  
Variceal Recurrence

Abstract Aim: The aim of this study was to compare the efficacy and safety of cap assisted endoscopic injection sclerotherapy(EIS) versus direct endoscopic injection sclerotherapy(EIS) in the management of patients with cirrhosis after esophageal variceal bleeding . Methods: Patients with cirrhosis suffering from esophageal variceal bleeding who underwent EIS with or without the help of a transparent cap in Shandong Provincial Hospital between Novermber December 2014 and April 2017 were included in this retrospective study. All of the cases included in the study were divided into two groups: Group A (EIS with a transparent cap, n=50), Group B (direct EIS, n=45). Data collected included patients’ demographics, details of the procedure, variceal eradication, variceal rebleeding, variceal recurrence and survival during the follow-up period. All data were expressed as mean ± SD. Quantitative variables were compared by Student t test, and qualitative variables were compared by the Fisher exact test or the chi-square test. A P value less than 0.05 was considered significant. Results: The mean duration of follow-up was similar in both groups(16.3±10.2 mo and 15.5±9.5 mo, respectively). To achieve the eradication of varices, the volume of sclerosant (64.86±10.62 ml vs 104.73±21.25 ml, P =0.044), the mean number of sessions (2.37±1.15 times vs 5.70±1.57 times, p =0.042), the time required to perform endoscopic treatment(6.57±1.50 minutes vs 11.22±2.29 minutes, P =0.049) and the time for the initial esophageal varices eradication were significantly reduced in the cap assisted EIS group than in the direct EIS group(5.43±1.38 weeks vs 8.93±1.5 weeks, P =0.041). The probability of variceal recurrence and rebleeding was significantly higher in the direct EIS group than in cap assisted EIS group. Only 22 patients (44%) developed complications in the cap assisted EIS group as compared to 30 patients ( P =0.039) in the EIS group. The probability of survival was similar in both groups ( P =0.133). Conclusion: EIS with a transparent cap is an effective and safe treatment for esophageal varices.

scholarly journals Endoscopic Sclerotherapy for Bleeding Oesophageal Varices: Experience in Gezira State, Sudan

2011 ◽  
Vol 4 ◽  
pp. CGast.S7146 ◽  
Author(s):  
Moawia Elbalal Mohammed
Keyword(s):  
Portal Hypertension ◽  
Standard Technique ◽  
Therapeutic Modality ◽  
Injection Sclerotherapy ◽  
Oesophageal Varices ◽  
Endoscopic Sclerotherapy ◽  
Endoscopic Injection Sclerotherapy ◽  
Endoscopic Injection ◽  
Vein Thrombosis ◽  
Central Sudan

Introduction Bleeding due to oesophageal varices is the most common cause of upper gastrointestinal tract haemorrhage in Gezira State, Central Sudan. Endoscopic injection sclerotherapy (EST) is a valuable therapeutic modality for the management of variceal bleeding. Other options for treatment such as variceal band ligation are either expensive or unavailable. Objectives A retrospective study to evaluate the outcome of (EST) in the management of bleeding oesophageal varices due to portal hypertension in Gezira State, the centre of a developing country, Sudan. Methods A total of 1073 patients, during 2001-2010, were carefully selected particularly those with bleeding oesophageal varices consequent to portal hypertension. EST was performed using a standard technique and ethanolamine oleate (5%) was utilized as sclerosing agent. Results There were 777 males (72.4%) and 296 females (27.6%) in a ratio of 2.6. The causes of portal hypertension were found to be schistosomal periportal fibrosis (PPF) in 1001 (93.3%) patients, liver cirrhosis in 60 (5.5%) mixed PPF and cirrhosis in seven (0.7%) and portal vein thrombosis in five (0.5%) patients. Full obliteration of varices required a mean of four sessions with a range of 2-6. In the present study 350 (32.6%) patients have been followed up until complete sclerosis of varices. Conclusion This study provides evidence that endoscopic injection sclerotherapy is an important component in the management of bleeding oesophageal varices caused by hypertension. It is a safe and effective procedure.

Sign in / Sign up

Export Citation Format

Share Document